Navigation Links
Max Neeman International Initiates Advisory Committee to Advance and Improve the Conduct of Complex Neurological Trials in India
Date:2/14/2011

RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2011 /PRNewswire/ -- India's premier CRO, Max Neeman, participated in the 59th annual Neurological Society of India & Congress of Neurological Surgeons (NEUROCON) held in Jaipur, India this past December.  The event was a convergence of leading neuroscientists, neurosurgeons, neurologists, physicians, surgeons, biotechnologists and researchers from across the globe to discuss advances made in the area of Neurology & Neurosurgery.

(Logo: http://photos.prnewswire.com/prnh/20110105/CL25129LOGO)

Max Neeman brought together USA and India based renowned group of Neuro and Spinal surgeons from prestigious hospitals across India and USA to form an advisory committee.

The Advisory Committee is to develop strategies for clinical research across newer therapies for central nervous system disorders.  Regulatory challenges and technical issues along with associated strategies of conducting the clinical trials of newer therapies in India were planned.

Max Neeman has conducted approximately 10% surgical intervention trials to date of over 230 trials awarded.  As part of the Max India Group, Max Neeman collaborates with 'Max Healthcare's' top physicians and neurosurgeons across India including Neurosciences departments, and one dedicated Neurological Institute, as part of the [8] hospital group; Max Healthcare.

About Max Neeman International

Max Neeman International is one of the leading and largest CROs in India and the clinical research arm of healthcare conglomerate, Max India.  Our specialty is that we offer services for the successful conduct of Phase I-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 certified CRO for Monitoring, Site Management and Data Management Services. The company has 6 regional offices and 175 sites across 31 cities. Contact Donald Swankie, Vice President USA via email to donald.swankie@neeman-medical.com or call +1.919.424.3345.  www.neeman-medical.com

About Max Healthcare

Also part of the Max India group, Max Healthcare is part of a leading chain of hospitals in India.  Its state of the art infrastructure, top-notch physicians, and most advanced technologies makes it one of the best hospitals in the country. www.maxhealthcare.in


'/>"/>
SOURCE Max Neeman International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Indias Favorable and Progressive Regulatory Environment Causes Accelerated Growth of Max Neeman Internationals Regulatory Services
2. Max Neeman International Signs Agreement for Data Management/EDC of Large Phase IV Trials from Multiple Sites
3. Max Neeman International to Open Phase I/IIa Unit
4. International Isotopes Inc. Announces a Shareholder Conference Call for February 7, 2011
5. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
6. 4th International Conference on Electrophoretic Deposition
7. Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit
8. Cellular Dynamics International to Present at 29th Annual JPMorgan Healthcare Conference
9. Halt Medical Presents Strong Results of International Fibroid Studies at National Institutes of Health Global Congress
10. Web of international collaboration boosts worldwide nanotechnology research
11. ViroPharma Incorporated and Idis Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... DIEGO , June 22, 2016 ... that will allow them to produce up to ... from one lot within one week. These high-quality, ... time laboriously preparing cells and spend more time ... possible through a proprietary, high-volume manufacturing process that ...
Breaking Biology Technology:
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
Breaking Biology News(10 mins):